Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities.

Molecular cell | 2010

Genome-scale studies have revealed extensive, cell type-specific colocalization of transcription factors, but the mechanisms underlying this phenomenon remain poorly understood. Here, we demonstrate in macrophages and B cells that collaborative interactions of the common factor PU.1 with small sets of macrophage- or B cell lineage-determining transcription factors establish cell-specific binding sites that are associated with the majority of promoter-distal H3K4me1-marked genomic regions. PU.1 binding initiates nucleosome remodeling, followed by H3K4 monomethylation at large numbers of genomic regions associated with both broadly and specifically expressed genes. These locations serve as beacons for additional factors, exemplified by liver X receptors, which drive both cell-specific gene expression and signal-dependent responses. Together with analyses of transcription factor binding and H3K4me1 patterns in other cell types, these studies suggest that simple combinations of lineage-determining transcription factors can specify the genomic sites ultimately responsible for both cell identity and cell type-specific responses to diverse signaling inputs.

Pubmed ID: 20513432 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK063491-039003
  • Agency: NCI NIH HHS, United States
    Id: R01 CA052599-19
  • Agency: NIDDK NIH HHS, United States
    Id: U19 DK062434-080007
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK063491-029003
  • Agency: NIDDK NIH HHS, United States
    Id: U19 DK062434-060007
  • Agency: NIDDK NIH HHS, United States
    Id: U19 DK062434
  • Agency: NCI NIH HHS, United States
    Id: R01 CA052599-20
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK063491
  • Agency: NCI NIH HHS, United States
    Id: R01 CA054198
  • Agency: NCI NIH HHS, United States
    Id: R01 CA052599-17
  • Agency: NCI NIH HHS, United States
    Id: R01 CA052599-18
  • Agency: NCI NIH HHS, United States
    Id: R01 CA078384
  • Agency: NIGMS NIH HHS, United States
    Id: P50 GM081892-01A1
  • Agency: NIGMS NIH HHS, United States
    Id: P50 GM081892
  • Agency: NHLBI NIH HHS, United States
    Id: HC088093
  • Agency: NHLBI NIH HHS, United States
    Id: F32 HL083752
  • Agency: NCI NIH HHS, United States
    Id: R01 CA052599
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK091183
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK063491-019003
  • Agency: NIDDK NIH HHS, United States
    Id: U19 DK062434-08S10007
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK063491-049003
  • Agency: NIDDK NIH HHS, United States
    Id: DK62434
  • Agency: NIDDK NIH HHS, United States
    Id: DK063491
  • Agency: NCI NIH HHS, United States
    Id: CA52599
  • Agency: NIDDK NIH HHS, United States
    Id: U19 DK062434-070007

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Charles River Laboratories (tool)

RRID:SCR_003792

Commercial organism provider selling mice, rats and other model animals. American corporation specializing in a variety of pre-clinical and clinical laboratory services for the pharmaceutical, medical device and biotechnology industries. It also supplies assorted biomedical products and research and development outsourcing services for use in the pharmaceutical industry. (Wikipedia)

View all literature mentions